Free Trial
NYSE:SNN

Smith & Nephew SNATS (SNN) Stock Price, News & Analysis

Smith & Nephew SNATS logo
$37.10 -0.21 (-0.56%)
Closing price 09/18/2025 03:59 PM Eastern
Extended Trading
$37.03 -0.07 (-0.18%)
As of 04:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Smith & Nephew SNATS Stock (NYSE:SNN)

Advanced

Key Stats

Today's Range
$36.92
$37.15
50-Day Range
$29.35
$38.72
52-Week Range
$23.69
$38.79
Volume
419,060 shs
Average Volume
632,929 shs
Market Capitalization
$16.16 billion
P/E Ratio
17.18
Dividend Yield
1.54%
Price Target
$36.00
Consensus Rating
Hold

Company Overview

Smith & Nephew SNATS Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

SNN MarketRank™: 

Smith & Nephew SNATS scored higher than 61% of companies evaluated by MarketBeat, and ranked 427th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Smith & Nephew SNATS has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 6 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Smith & Nephew SNATS is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Smith & Nephew SNATS has only been the subject of 1 research reports in the past 90 days.

  • Read more about Smith & Nephew SNATS's stock forecast and price target.
  • Earnings Growth

    Earnings for Smith & Nephew SNATS are expected to grow by 18.34% in the coming year, from $1.69 to $2.00 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Smith & Nephew SNATS is 17.18, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 281.55.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Smith & Nephew SNATS is 17.18, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.48.

  • Price to Earnings Growth Ratio

    Smith & Nephew SNATS has a PEG Ratio of 1.03. PEG Ratios around 1 indicate that a company is correctly valued.

  • Price to Book Value per Share Ratio

    Smith & Nephew SNATS has a P/B Ratio of 3.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.60% of the float of Smith & Nephew SNATS has been sold short.
  • Short Interest Ratio / Days to Cover

    Smith & Nephew SNATS has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Smith & Nephew SNATS has recently decreased by 8.10%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Smith & Nephew SNATS pays a meaningful dividend of 2.39%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Smith & Nephew SNATS does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Smith & Nephew SNATS is 26.39%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Smith & Nephew SNATS will have a dividend payout ratio of 28.50% next year. This indicates that Smith & Nephew SNATS will be able to sustain or increase its dividend.

  • Read more about Smith & Nephew SNATS's dividend.
  • Percentage of Shares Shorted

    0.60% of the float of Smith & Nephew SNATS has been sold short.
  • Short Interest Ratio / Days to Cover

    Smith & Nephew SNATS has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Smith & Nephew SNATS has recently decreased by 8.10%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Smith & Nephew SNATS has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Smith & Nephew SNATS this week, compared to 4 articles on an average week.
  • Search Interest

    4 people have searched for SNN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Smith & Nephew SNATS insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.00% of the stock of Smith & Nephew SNATS is held by insiders.

  • Percentage Held by Institutions

    Only 25.64% of the stock of Smith & Nephew SNATS is held by institutions.

  • Read more about Smith & Nephew SNATS's insider trading history.
Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew SNATS and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNN Stock News Headlines

Smith & Nephew Announces Share Sale by Executive
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Smith & Nephew Announces Updated Share Capital Structure
What Does the Market Think About Smith & Nephew?
Smith & Nephew: Doing Better And Still Offers Value
See More Headlines

SNN Stock Analysis - Frequently Asked Questions

Smith & Nephew SNATS's stock was trading at $24.58 at the beginning of the year. Since then, SNN stock has increased by 50.9% and is now trading at $37.10.

Smith & Nephew SNATS, Inc. (NYSE:SNN) posted its quarterly earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.59.

Top institutional investors of Smith & Nephew SNATS include Bank of Montreal Can (0.78%), River Road Asset Management LLC (0.73%), Scharf Investments LLC (0.48%) and Brandes Investment Partners LP (0.37%).

Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Smith & Nephew SNATS investors own include JPMorgan Chase & Co. (JPM), Johnson & Johnson (JNJ), PepsiCo (PEP), Taiwan Semiconductor Manufacturing (TSM), McDonald's (MCD), Sanofi (SNY) and Alibaba Group (BABA).

Company Calendar

Last Earnings
11/17/2014
Today
9/19/2025
Record date for 11/7 Dividend
10/03/2025
Ex-Dividend for 11/7 Dividend
10/03/2025
Dividend Payable
11/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:SNN
CIK
845982
Employees
17,349
Year Founded
1856

Price Target and Rating

High Price Target
$36.00
Low Price Target
$36.00
Potential Upside/Downside
-3.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
17.18
Forward P/E Ratio
21.95
P/E Growth
1.03
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.60
Current Ratio
3.00
Quick Ratio
1.40

Sales & Book Value

Annual Sales
$5.81 billion
Price / Sales
2.78
Cash Flow
$3.14 per share
Price / Cash Flow
11.82
Book Value
$12.04 per share
Price / Book
3.08

Miscellaneous

Outstanding Shares
435,480,000
Free Float
431,130,000
Market Cap
$16.16 billion
Optionable
Optionable
Beta
0.71

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:SNN) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners